drugset / Trial / NCT01461785

The Use of Activated Platelet Rich Plasma (PRP) in Human Autologous Fat Transfer

NCT01461785

Phase 2/3 Completed 25 enrolled Bergman Clinics Zimmer Biomet · collab
RandomizedParallel-groupDouble-blindBasic science

Summary

In this prospective, randomized clinical trial, lipofilling of the midface with Platelet Rich Plasma (PRP) is compared with lipofilling of the midface without PRP. The main objective of this study is to investigate the effect of the addition of PRP to the autologous fat transfer on local skin quality improvement, graft survival, and recovery after the procedure.

Timeline

Start
2012-04
Primary completion
2015-01
Completion
2015-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified 3 ml

Indications

No indication recorded.